Slowing Parkinson's disease progression: recent dopamine agonist trials.
Montgomery
Erwin B
EB
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D016477:Artifacts; D052160:Benzothiazoles; D002986:Clinical Trials as Topic / Q000379:methods; D018450:Disease Progression; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D012720:Severity of Illness Index; D016037:Single-Blind Method; D013844:Thiazoles / Q000627:therapeutic use
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D013844:Thiazoles; D007980:Levodopa; D000077487:Pramipexole